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AKTIVITI ANTIHIPERGLISEMIK EKSTRAK DAN FRAKSI TINOSPORA 
CRISPA PADA TIKUS 
 
ABSTRAK 
Tinospora crispa (Menispermaceae) yang nama tempatanya dikenali sebagai 
"akar patawali", telah lama digunakan dalam perubatan tradisional Malaysia untuk 
rawatan kencing manis. Tujuan kajian ini adalah untuk mengesahkan kesan 
hipoglisemik dan antihiperglisemik ekstrak Tinospora crispa yang berbeza beza 
dalam tikus normal dan tikus diabetik aruhan streptozotocin (STZ). Serbuk batang 
Tinospora crispa kering diekstraksi secara berturut-turut scara maserasi dengan eter 
petroleum, kloroform, metanol dan air untuk menghasilkan empat ekstrak. Tidak satu 
pun daripada keempat-empat ekstrak (1.0 g / kg) yang diberikan secara oral dapat 
menurunkan paras glukosa darah tikus normal yang menunjukkan bahawa      
ekstrak-ekstak tersebut tidak mempunyai sebarang kesan hipoglisemik.        
Keempat-empat ekstrak juga tidak menghalang kenaikan paras glukosa darah tikus 
yang dimuatkan dengan  glukosa secara intraperitoneal. Pemberian ekstrak secara 
oral 1 g / kg setiap hari selama 9 hari pada tikus diabetik aruhan STZ mendapati 
hanya ekstrak air dapat mengurangkan paras glukosa darah secara signifikan           
(P <0.05) berbanding dengan kumpulan kawalan yang menunjukkan bahawa ekstrak 
air mempunyai kesan antihyperglisemik. Ekstrak air kemudiannya difraksikan untuk 
mendapatkan fraksi n-butanol dan fraksi air. Walau bagaimanapun, rawatan setiap 
hari untuk 12 hari mendapati hanya fraksi air (0.5 g / kg) menurunkan paras glukosa 
darah tikus diabetic aruhan-STZ. Penyaringan fitokimia ekstrak air Tinospora crispa 
menunjukkan kehadiran alkaloid, saponin dan glikosida. GC-MS fraksi air 
menunjukkan kehadiran dodesil akrilat, asid pentadekanoik dan asid propanoik 
xvi 
 
manakala analisis HPLC menunjukkan kehadiran asid galik dan salsolinol. Dodesil 
akrilat, asid pentadekanoik, asid propanoik dan asid galik telah dilaporkan sebelum 
ini memiliki kesan antidiabetik. Secara keseluruhan, hasil kajian ini menunjukkan 
Tinospora crispa mempunyai kesan antidiabetik yang mungkin menyokong 
penggunaannya di kalangan pesakit kencing manis. Beberapa sebatian yang 
dikenalpasti diatas mungkin telah menyumbang secara individu atau dalam gabungan 
kepada aktiviti antidiabetik tersebut. 
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ANTIHYPERGLCEMIC ACTIVITY OF TINOSPORA CRISPA 
EXTRACTS AND FRACTIONS IN RATS. 
 
ABSTRACT 
Tinospora crispa (Menispermaceae), locally known as “akar patawali”, has 
long been used in Malaysian traditional medicine for treatment of diabetes. The aim 
of this study was to verify the hypoglycemic and antihyperglycemic effects of 
different Tinospora crispa extracts in normal and streptozotocin (STZ)-induced 
diabetic rats. Pulverized Tinospora crispa dried stems were extracted successively by 
maceration with petroleum ether, chloroform, methanol and water to yield the four 
extracts. None of the four extracts (1.0 g/kg) administered orally lowered the blood 
glucose levels of normal rats which suggest that they have no hypoglycemic effect. 
The four extracts also did not inhibit the rise of blood glucose level of glucose 
intraperitoneally loaded rats. Daily oral administration of the extract 1 g/kg for         
9 days in STZ-induced diabetic rats found that only the water extract managed to 
lower the blood glucose levels significantly (P<0.05), as compared with the control 
group which suggests that it has antihyperglycaemic effect. The water extract was 
then fractionated to obtain n-butanol and aqueous fractions. However, daily 
treatment for 12 days found that only water fraction (0.5 g/kg) lowered the blood 
glucose level of STZ-induced diabetic rats. Phytochemical screening of the water 
extracts of Tinospora crispa indicated the presence of alkaloids, glycosides and 
saponins. GC-MS of water fraction showed the presence of dodecyl acrylate, 
pentadecanoic acid and propanoic acid whereas HPLC analysis showed the presence 
of gallic acid and salsolinol. Dodecyl acrylate, pentadecanoic acid, propanoic acid 
and gallic acid have been previously reported to possess antidiabetic effect.  Overall, 
xviii 
 
the findings of this study showed Tinospora crispa possesses antidiabetic effect 
which may justified its use in diabetic patients. Some of the identified compounds 
above might have contributed individually or in combination to its antidiabetic 
activity.   
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CHAPTER ONE : INTRODUCTION 
 
1.1 Introduction 
The use of herbal remedies, in different cultures and traditional medicines, have been 
practiced for centuries because of traditional beliefs and out of habits. In majority of the 
world population, including those of Asian and western countries, the modern medicine has 
prominently taken over the life style, practice and use of herbal remedies to meet health 
needs. Surprisingly, in this modern era, people are still using herbal medicines in           
conjunction with modern conventional methods. Worldwide, especially in developed    
countries, a substantial amount of money is being annually spent on research aimed at   
identifying and assessing herbal products. A number of pure isolated herbal compounds, 
such as taxol and artemisinin, have been derived from plants and have already been through 
clinical development. In general, herbal products are widely believed to cause less adverse 
side effects, and are less potent compared to synthetic and modern pharmaceuticals.    
However, their use can play a key role in the reduction of the national health expenditure 
(Holt & Chandra, 2002). 
These studies investigating the biologically active constituents of medicinal plants, 
have made it possible for the development of new drugs for clinical use (Kamboj &    
Dhawan,. 1982). Natural products serve as a source of lead compounds for drug              
development. In some Asian countries such as China, India, Japan and Korea, herbal    
remedies have been officially recognized (World Health Organization., 2003).  
2 
 
The reawakening, obviously if any real improvement in healthcare systems and          
research especially in Asia and the developing countries were to be made, there should be 
an optimal use of all their natural resources and potential, and of course traditional herbal 
medicines are undoubtedly amongst the best options. International organizations, like the 
World Health Organization (WHO), have showed enthusiasm regarding to the use of herbal 
medicine, and it suggests reinforcing the use of traditional medicines which may spark 
globally. In some countries, traditional medicinal plants have come to be placed on the 
same footing as modern medicines and sometimes even more popular. This is the time to 
accept the importance of medicinal plants such as Tinospora crispa as an alternatives for 
health care (Farnsworth & Bingel,1977) 
 
3 
 
1.2 Diabetes Mellitus 
Diabetes mellitus (DM) as a chronic metabolic disorder, has long been a major public 
health problem and its prevalence, in the modern world, is increasing. The World Health 
Organization estimated that in 2000, diabetic mellitus affected 171 million individuals 
globally, and moreover it has been projected that, by 2030, this number would increase to 
366 million patients (Whiting et al., 2011). It is a group of metabolic diseases characterized 
by chronic high blood glucose levels, caused either by the  inability of the β-cells of      
pancreas to produce adequate amount of  insulin, or  failure of the target cells  (particularly 
the skeletal muscles and adipose tissues) to respond to secreted insulin (Shoback, 2008). 
Food digestion always commences with amylase in the mouth terminating in the small   
intestines. During the digestion process in the intestines, food is converted to glucose, a 
universal source of energy. As more foods carbohydrate change to glucose and the blood 
glucose level, this main source of energy in body reaches the postprandial level a signal 
given to the pancreas causes it to release the hormone insulin into the blood stream,        
enabling the cells to use the readily available glucose (Holt et al.,2003). 
The chronic high blood glucose level (hyperglycemia), produces classical symptoms, 
such as polyuria (frequent urination), polydipsia (increased thirst) and polyphagia           
(increased hunger). The treatment focus therefore, is to maintain steady blood glucose  
within physiological limits (euglycemia). However, this is often scarcely achieved in    
practice, hence there are reported occasional incidences of hypoglycemia, besides the grave 
side effects of some of the conventional drugs in use. Moreover, along with                 
pharmacological treatment, non-pharmacological treatment measures have also become 
essential for the prevention and management of diabetes mellitus, due to the variety of 
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complications accompanying DM, such as malnutrition and cardiovascular diseases.       
For instance, dietary advice given to older people with diabetes would be intended to  
maintain adequate nutrition, thereby complementing observed tissue wasting, as diabetes 
also make damage on nerve supply and further muscle wasting which referred as diabetic  
amyotrophy and mostly effect on  hips and shoulders muscles. Furthermore, besides their 
nutritional complementary role, most leafy vegetables also exert therapeutic functions, for 
which reason they are referred to as functional foods. Natural products including medicinal 
plants have equally been used as source of drugs in traditional management of diabetes 
with the aim to circumvent the drawbacks of conventional medication, and in most         
instances to complement their therapeutic effect (Nascimento et al., 2006).  
At the moment, an estimated 285 million individuals suffer from Type II diabetes 
which correspond to 90% of all diabetic cases worldwide. In Malaysia alone 1.6 million             
individuals are affected by Type II diabetes (Saleh et al., 2013), thereby suggesting that this 
is no longer a disease associated with middle and old age individual. Recent evidence   
suggests that children as young as 10 years old may also be affected, indicating that, a    
holistic approach in sourcing a cure is urgently needed. Diabetic is also at high risk of 
macrovascular complications, such as ischemic heart disease and strokes. Some risk factors 
in diabetes include having a family history of heart disease and  high cholesterol  levels. 
Actually high level of some cholesterols, for instance low density lipoprotein (LDL) as one 
of the five major groups of lipoproteins and also triglycerides, can increase the risk of heart 
disease. They can build up inside of blood vessels, leading to the narrowing and hardening 
of arteries, blocking the arteries and raising the risk of getting heart disease and strokes 
(Almdal et al., 2004).This may be attributed in part to the late diagnosis and poor glycemic 
control. However, being highly associated with components of the metabolic syndrome, 
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such as obesity, hypertension (10-37%) and hyperlipidemia (63-76%), diabetes actively 
predisposes DM patients to such complications (Funk et al., 2004). More worrisome is the 
fact that many of those affected by DM may do not even know that they suffer from the 
disease. Hence, it is really necessary to discover new and better methods for treating and 
controlling DM, such as the utilization of herbs. 
 
1.3 Classification of Diabetes Mellitus 
Diabetes is generally classified into insulin dependent diabetes mellitus (IDDM),  
which is commonly known as Type -I diabetes, and non-insulin dependent diabetes     
mellitus (NIDDM) known as Type -II diabetes. Presently, as many types of anti-diabetic 
drugs are available, they are typically classified according to various criteria, such as the 
type of diabetes they are used for, patients age, or other factors like history of any particular 
disease, inherited sickness or even gender and physical factors which is contributing to the 
disease manifestation. Type I diabetes mostly affects children with an onset before the 15
th
 
birthday (Harjutsalo et al., 2008) and since insulin is destroyed when ingested orally, the 
treatment have to be administered through subcutaneous injections. On the other hand, 
Type II diabetes usually affects adults, especially the obese. These patients may not require 
insulin treatment and sufficient to be given with oral antidiabetic agent. Some agents      
induce greater insulin production, sensitize the tissues to insulin, and prevent excessive 
glucose absorption from gastrointestinal tract are available for non-insulin dependent      
diabetes mellitus patients. Among the five classes of anti-diabetic drugs the two main   
classes widely used are sulfonylureas (e.g. glibenclamide) and biguanides (e.g.metformin), 
which can be taken separately or in combination (Phung et al., 2010) 
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1.4 . Pancreas   
The pancreas is an integral part of the digestive system. Due to its exocrine and         
endocrine secretions, the pancreas as an exocrine gland always considered to be a mixed 
gland. Pancreas secretes digestive enzymes and alkaline substances into the small           
intestines. It acts as an endocrine gland as well as secreting certain hormones into the blood 
stream (Gradwohl et al., 2000).  
Hormones from clusters of cells, referred to as Islets of Langerhans or the pancreatic    
islets, are stored and secreted in the human body. Those clusters contain four special groups 
of cells: alpha (α), beta (β), delta (δ) and F cells. Insulin and glucagon are the main       
hormones which help regulate glucose metabolism. Alpha cells, responsible for glucagon 
secretion, are effective in raising blood glucose levels. Conversely, beta cells are           
specialized in producing insulin to lower blood glucose levels. Delta cells secrete the         
hypothalamic growth inhibiting hormone, while the F cells regulate the release of          
pancreatic digestive enzymes, such as the pancreatic polypeptide (Pritchett et al., 1995). 
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Figure 1.1.  The pancreas system (National cancer institute, Pancreatic Cancer, 05-07-2014. 
Retrieved from http://www.cancer.gov/types/pancreatic ) with modification.  
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1.4.1 Glucagon 
Glucagon is secreted by the alpha cells of the pancreas. It increases the               
concentration of cyclic AMP, derived from ATP in the liver cells, thereby causing the    
enzyme (phosphorylase) to be activated when the blood glucose level is low. For instance, 
glucagon will be higher between meals and during exercise. Glucagon as a polypeptide 
hormone is released in response to hypoglycemia and plays a role as a physiological    
regulator of the effects caused by insulin (Constantin et al., 1995).  
When the concentration of glucose falls in the blood and glucagon gets secreted, the 
liver responded by converting glycogen into glucose (glycogenolysis) to raise the blood   
glucose concentration. Glucagon stimulates the release of fatty acids and glycerol from the 
adipose tissue. This enzyme also separates glucose units from the branched glycogen    
molecules, and the free glucose units then enter the bloodstream to maintain the blood level 
of glucose at 70-110 mg/dl. For this reason, glucagon is considered to be hyperglycemic 
factor (DiCostanzo et al., 2007) 
 
1.4.2 Insulin 
Insulin is synthesized as pre-pro insulin. It contains A and B chains connected by 51 
amino acids, and linked by disulfide. Insulin as a peptide hormone released and synthesized 
from pancreatic β-cells at low basal rates. However, it gets stimulated to reach at much 
higher levels in response to a variety of stimuli, especially glucose. Insulin analogues have 
been commercially available for years as they have been synthesized to mimic human    
insulin (Ljungqvist, 2012).  
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1.4.2.1   Mechanism 
Beta cells in pancreas naturally produce insulin. The hormone sending signals to the 
cell receptors to absorb glucose from the blood and raises blood glucose levels in the cells 
(hypoglycemic effect). Insulin does not have an effect beyond that of lowering blood     
glucose concentration with respect to altering ris (Stratton et al., 2000). However, insulin is 
effective in increasing protein synthesis. Furthermore, it increases the conversion of       
glucose into fatty acids and promotes amino acid transport into the cells. 
 
1.5   Antidiabetic Drugs 
Modern day research on drug development associated in β-cell function of pancreas has 
produced several number of new drug compounds in the treatment of Type II or insulin  
dependent diabetes mellitus (Zhao et al., 2010). However, In Type I diabetes some     
treatment prevents the development of microvascular and produces neurologic             
complications (Ohkubo et al., 1995). 
 
1.5.1 Biguanides 
Biguanide refers to a class of drug which are using as an oral antihyperglycemic drugs 
for diabetes mellitus. The most popular example and the only widely available antidiabetic 
biguanide drug is metformin. It can also improve glycaemic control in overweight to obese 
individuals with type 2 diabetes (Gilbert et al., 2006).  Biguanides mechanism of action is 
to inhibit the liver from producing glucose and to help the body secrete insulin (Potenza et 
al., 2009). Except metformin other biguanides derivatives have been withdrawn from the 
market due to their toxic effects. 
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Figure 1.2. Chemical structure of metformin. 
 
 
 
1.5.2 Sulphonylureas 
Sulphonylurea derivatives is one of the earliest class of anti-diabetic drugs, that are 
used to management of diabetes mellitus type II. This group of drugs are metabolized by 
the liver. Sulphonylureas are known to be the ‘principal oral hypoglycemic agents’ in type 
II diabetes treatment. This class works by stimulating the β-cells in the pancreas to produce 
more endogenous insulin, and by increasing the circulating insulin to levels sufficient to 
overcome insulin resistance. This class of drug is generally taken one to twice a day before 
meals during treatment. Hypoglycemia is the possible side effect in all type of                
sulphonylurea. However, glipizide and glimepiride showing less hypoglycemic effects than 
the other drugs of this class (Pieber et al., 2003). Considering the fact that cardiac myocytes 
also express the same sulphonylurea receptor as the β-cells, these drug compounds may  
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potentially lead to cardiovascular toxicity. In this drug category most of the drugs names 
end with ‘ide’. Examples of sulphonylureas are glibenclamide which are also known as 
glyburide, glipizide, gliquidone, glyclopyramide, glimepiride , gliclazide, tolbutamide and 
tolazamid.  
 
1.5.3 Alpha-glucosidase inhibitors 
Alpha-glucosidase is an enzyme responsible for the breakdown of complex         
carbohydrates into di- and mono-saccharides in the distal duodenum and the proximal    
jejunum. Alpha-glucosidase inhibitors help the body to lower blood glucose level by  
blocking the break down of starches into glucose in the intestine. 
Miglitol, acarbose and voglibose are examples of alpha-glucosidase inhibitors. 
However, acarbose is the only commercialized α-glucosidase inhibitor. It is an                
oligosaccharide  produced by cultured strains of actinomycetes. It is a competitive inhibitor 
with low affinity for glucoamylase, and high affinity for sucrase and pancreatic α-amylase 
(Braun et al., 1995). The major effect of acarbose is reducing the risk for myocardial         
infarction in type 2 diabetic patients by controlling and improving the body weight and  
triglyceride levels (Hanefeld et al., 2004). 
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 DRUG COMMON NAME                                                 STRUCTURE 
 
Figure 1.3. Chemical structures of  important alpha-glucosidase inhibitor drugs.  
 
1.5.4 Thiazolidinedione  
Glitazones or thiazolidinediones are anti-diabetic drugs which improve insulin      
sensitivity in the muscles and also reduce glucose production in the liver. Thus, they are 
used in the treatment of type II diabetes. They also help to decrease the levels of             
triglycerides in the blood. Avandia and pioglitazone are the most popularly prescribed 
drugs of this class. However, due to some adverse reaction incidents, which included   
bladder cancer and heart attacks, they were banned by the European Medicines Agency in         
September 2010. Nevertheless, for pioglitazone, the adverse effect has not been deemed 
sufficient to justify restriction on its treatment use in the UK (Dunn et al.,  2011).  
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1.5.5 Incretin mimetics / GLP-1 analogues 
Incretin mimetics or glucagon like peptide-1 receptor agonists (GLP-1) analogues 
are injectable drugs used for the treatment of Type II diabetes. As the level of glucose in 
the body increases more hormone of GLP-1 also will be produced. While food is           
consumed, the body releases GLP-1, and the hormone moves to the pancreas. They will 
increase the amount of insulin released from the beta cells of the islets of Langerhans and 
decrease the release of glucagon. They are known to be inhibitors that stop the protein    
dipeptidyl peptidase-4 from destroying the incretin hormones (Ellingsgaard et al., 2011). 
 
1.5.6 Meglitinide 
Meglitinides are from the class of drugs which stimulate β-cells to release more    
insulin and this class drugs are used to treat diabetes type II, The mechanism of action is 
similar to sulphonylureas. Since meglitinides and sulphonylureas both stimulate to release 
insulin, hypoglycemia or low blood glucose is the possible side effect on patients using 
them. Some example of this class are nateglinide and repaglinide ( Lorenzati et al., 2010). 
 
1.5.7 Dipeptidyl peptidase-4 inhibitor / Gliptins 
Dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitors) or Gliptins represent an          
innovative approach and are a class of oral hypoglycemic which are used for treatment of 
type II diabetes mellitus. DPP-4 inhibitors are attached to the DPP-4 enzyme and prevent 
them from assisting in the breaking down of Glucagon-like peptide-1 (GLP-1), (Monami et 
al., 2011).   
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Drugs of this class stimulate the production of insulin and reduce the production of 
glucagon, especially during digestion where it decreases gastric emptying, thus it helps  
decreasing the blood glucose levels. The effect of this agent inhibitor is that DPP-4 will be 
released throughout the day and their levels increased at meal times (Ahrén et al., 2011). 
Example of some drugs belonging to this class are sitagliptin, vildagliptin, saxagliptin and 
linagliptin. Linagliptin was approved as a treatment for Type II diabetes by the U.S. Food 
and Drug Administration (FDA) in May 2011. 
 
 
Figure 1.4. Mechanism of DPP-4 inhibitors and GLP-1.  
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1.5.8 Insulin 
Insulin is one of the main hormones that regulate blood glucose levels. It can        
directly lower the glucose levels by increasing the uptake of glucose to the muscle and fatty 
tissue, and reducing the release of glucose from the liver. A number of different types of 
insulin preparations are available in the medications. Insulin is usually prescribed for      
patients suffering from Type I DM; however, it may also be prescribed for patients with 
Type II DM who have not responded well to strict diets, exercise and oral antidiabetic 
drugs. Some insulin act only for a few hours duration, but some exert their effects for as 
long as one whole day (Sussman et al., 2012). 
 
1.5.8.1 Rapid action insulin 
To control blood glucose levels promptly, rapid-acting insulin is administered for 
adults with type II diabetes, and also for adults and children (4 years and above) with type I       
diabetes. These types are usually taken just before or during meal. They act very quickly to 
minimise the increase of blood glucose level after eating. This type of insulin should be 
given within 15 minutes before, or 20 minutes after starting a meal. The action of           
rapid-acting insulin lasts for about 4 hours. As they act very quickly, they can lead to an 
increased chances of hypoglycemia (Heinemann, 2010). 
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1.5.8.2 Short action insulin 
Regular insulin is short-acting or specifically, it has an onset of action that normally 
reaches the  bloodstream within 30 minutes to an hour after injection and a duration of   
action of 4 to 8 hours (Siebenhofer et al., 2006). 
 
1.5.8.3 Intermediate action insulin 
Neutral Protamine Hagedorn  (NPH) insulin  which is also known as Humulin N, 
Novolin N, Novolin NPH, NPH Iletin II, and iso-phane insulin, is an intermediate acting 
insulin product given to help control the blood sugar level of those with diabetes. This type 
of insulin is absorbed slowly and generally reaches the bloodstream from about 2 to 4 hours 
after it is injected. Thus, it has a formulation that contains a substance of action, and it lasts 
longer. Its duration of action is between 10 and 20 hours and after approximately 20 hours, 
the whole dose has been absorbed. In 1936, Nordisk formulated pig insulin by adding    
neutral protamine to regular insulin, and NPH was created (Peterson, 2006). 
 
1.5.8.4 Long action insulin 
Long acting insulin preparations are prescribed for a  number of different types of      
diabetes and they have an onset of action of around 1 hour, and a duration of action of 14 to 
24 hours. However, the action of those insulin products may vary substantially from one 
person to another. Given to certain patients, it may vary by one day. Lantus
 
is a clear      
insulin preparation. It was the first real basal insulin that lasted for 24 hours, almost with no 
peak. Long acting insulins are available in animal and analogue forms, in the UK analogue 
insulins are more preferred by the National Health Service because the insulins have no 
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peak activity. As such, it allows for a consistent delivery of activity through the day.   
However, it may not be used concurrently with rapid insulin. Some patients may need to 
use this product twice daily for an action duration of 24 hours  (Peterson, 2006). 
 
 
 
 
Figure 1.5 Antidiabetic drugs action on different organs  
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1.6   The plant, Tinospora crispa 
1.6.1  Botanical aspects 
Kingdom                    :  Plantae 
Subkingdom              :  Tracheobionta 
Division                     :  Magnoliophyta 
Class                          :  Magnoliopsida 
 Scientific name         :            Tinospora crispa 
Synonym                    :  Tinospora cordifolia 
Family                        :            Menispermaceae 
Local name                 :            Akar patawali 
Part used                     :            Stem 
 
 
 
Figure 1.6 The stem of  Tinospora crispa  plant 
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Figure 1.7 The Tinospora crispa  plant 
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1.6.2 Background 
Tinospora crispa is an indigenous medicinal plant that belongs to the                 
Menispermaceae family. Locally, it is known as  akar patawali and akar seruntum. It is a 
medicinal plant that commonly grows wildly in the Asian countries, such as Malaysia,    
Indonesia, Thailand, India and the Philippines. The leaves, the roots and the stems, all have 
been claimed to have miraculous properties in curing a spectrum of diseases.  
In rural southern India, Tinospora crispa has a reputation of being a hypoglycemic 
agent. For many years, Tinospora crispa has also been used in southern eastern Asia,     
especially in China and Malaysia as a treatment for various ailments, such as prurigo,     
eczema, impetigo and oxidative stress conditions. It also has been known to have            
anti-allergic and antiviral properties as well. A decoction of Tinospora crispa as a whole is 
used in the treatment of cholera throughout the Malay communities, and a decoction of its 
stem is used for various therapeutic purposes such as managing hypertension, stimulating 
the appetite, and protecting against mosquito bites. It is also used to treat ailments like 
jaundice, wounds, intestinal worms, skin infections, tooth and stomach aches, coughs, 
asthma, and pleurisy (Rahman et al., 1999). In Thailand, a decoction from the stems has 
been used as antipyretic syrup, for the treatment of internal inflammations, to reduce thirst, 
to cool down body temperatures, and to maintain good health (Dweck & Cavin, 2006).  
Tinospora crispa was also used as an anti-parasitic agent for humans and for      
domestic animals (Noor & Ashcroft, 1989). This plant was able to cause a reduction in   
serum glucose level in diabetic rats and its hypoglycemic effect was probably due to an  
insulinotropic activity. It was also shown to increase peripheral utilization of glucose and to 
inhibit hepatic glucose release.  
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Tinospora crispa has been scientifically demonstrated to possess anti-filarial,       
anti-malarial, anti-pyretic (Kongkathip et al., 2002), and antihyperglycemic properties 
(Noor & Ashcroft, 1989). Also antinociceptive and anti-inflammatory activities of the   
ethanol extract of Tinospora crispa stem has been demonstrated (Sulaiman et al., 2008). In 
Indonesia (Borneo), it is used as a treatment for lumbago (Dweck and Cavin, 2006), in 
South-East Asia, in countries like Malaysia and China, an aqueous extract of Tinospora 
crispa is taken orally as a diabetes treatment.   
Previous studies conducted on this herb showed that its aqueous extract was able to 
lower blood glucose levels in moderately diabetic rats. Its hypoglycemic effect was         
attributed to its insulinotropic activity (Noor & Ashcroft, 1989), However, according to a 
human research on glucose and insulin levels in healthy subjects and diabetic patients with 
type 2 diabetes mellitus in Mahidol university of Bangkok,  ingestion of 250 g ethanolic 
extract of Tinospora crispa obtained using Soxlet, did not reduce the blood glucose and 
insulin levels of healthy and diabetic human volunteers and have no ability to sensitize β 
cells to secrete insulin (Klangjareonchai & Roongpisuthipong, 2011).  
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1.7 Antihyperglycemic drug methodologies 
To investigate the activity of a drug and its use as a treatment for diabetes, more 
systematic approaches are require. Certain approaches of bioassay-guided drug discovery 
to optimize time and resources are available, which can be divided into the two main    
classes of in vitro and in vivo techniques. 
 
1.7.1 In vitro techniques 
To study on extracts and fractions of Tinospora crisp and to assess the potential of           
hypoglycemic agents on the release of insulin, many different in vitro techniques have been 
developed such as intact isolated islets techniques, perfuse pancreas methods and Scattered 
islet cell techniques. The features of insulin and glucagon released as a result of the use of 
agents had been comparatively studied (Weir et al., 1986).  
The majority of researchers who are active in the drug discovery industry   prefer to 
use in vitro studies as first line screening models (Berkowitz & Katzung, 2001). The recent 
research on the mechanisms of sulfonylureas the biochemical basis and diabetes the cellular 
and sub-cellular levels was mostly done with cultured β-cells (Lienhard et al., 1992).     
Furthermore, the results of animal experiments are sometimes impossible to be extrapolated 
to humans. Nevertheless, when conducted properly, animal experiments could provide vital 
information on the drugs being examined. In order to study on in vitro insulin                 
internalization and glucose transport in peripheral tissues and insulin resistance, the most 
common techniques involve cultures of adipocytes derived from rat epididymal pads,    
skeletal or abdominal muscle strips or cells (Reecy et al., 2003). Also, the effect of natural 
products on glucose absorption has also been studied by using fragments or a homogenate 
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of the rat’s small intestine Jejenum (Hikino et al., 1989). Eventually, in several of the      
bioassays, the measurement of insulin levels shows a determining effect. However, in some 
situation in vitro techniques are not able to simulate the real life conditions owing to the 
effect of the different instrument using in study or the chemicals on cell culture and isolated 
tissue. Therefore having in vivo models, using animals and other pharmacological methods 
is inevitable (Lipinski & Hopkins, 2004) 
 
1.7.2 In vivo techniques 
In vivo techniques are applied for the study of hypoglycemic activity which make 
use of animals for activity assessments with the aim to study the effects of therapeutic  
agents by monitoring the blood glucose levels of animals with normoglycaemia and/or   
induced-hyperglycaemia by loading with glucose, also an isolated nitrosourea glycoside 
from Streptomyces achromogenes that causes degeneration of pancreatic β-cells           
(Srivastava et al., 2007). 
Diabetic humans may sometimes be grouped for in vivo studies. However, in       
animals, diabetes gets experimentally induced by using drugs such as alloxan and        
streptozotocin which selectively destroying β-cells. A single subcutaneous injection in a 
normal rat can produce an experimental model of Type I or II diabetes mellitus. However, 
results of adipocyte insulin binding and glucose transport (Fantus et al., 1987), concluded 
that the streptozotocin injected diabetic rats did not provide a representation of human   
non-insulin dependent diabetes mellitus (NIDDM) characterized by deficient insulin              
biosynthesis and release in response to glucose and diminished pancreatic insulin content 
(Fantus et al., 1987). The history and the mechanisms of action of alloxan, a pyrimidine 
derivative, have been reviewed by Lenzen and Panten (1988). Considering the fact that  
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animal tests always reveal little information on the   mechanism of action of the compound, 
and involve with financial restrictions on maintaining animals, and social restrictions on the 
extensive use of animals in experimentation, shortage of perfect models for Type I and II 
has always been observed. 
 
1.8 Hypoglycemia studies 
1.8.1  Mechanisms of action of hypoglycemic agents 
Hypoglycemic properties denote the qualities of certain agents in rapidly reducing 
the concentration of glucose in the blood and the term hypoglycemia "low blood glucose 
levels" experiment classifying on acute tests. An inadequate supply of glucose to the   
nervous    system may however cause serious brain problems, from mild dysphoria to more 
serious issues such as seizures unconsciousness. It can occur due to a wide range of internal      
factors and permanent brain damage or death. It also may cause a variety of other side    
effects. The activity of herbal extracts in controlling blood sugar levels may be attributed to 
certain properties, thereby allowing them to act at the pancreatic level and stimulate β-cells 
to release insulin.   
 
1.8.2 Glucose loading tests 
To evaluate the anti-hypoglycemic activity of a drug following oral administration 
of glucose, traditionally, two tests have been used on animals: a hypoglycemic test      
spanning a duration of 7 hours on normal groups and a glucose tolerance test of a duration 
of 2 hours on glucose loaded on normal groups. IPGTT and OGTT tests are the two most 
classical tests used in diagnosing diabetes Glucose Tolerance Test. According to the   
American Diabetes Association, to verify the diagnosis of Diabetes Mellitus and the       
